anordrin has been researched along with Non-alcoholic-Fatty-Liver-Disease* in 1 studies
1 other study(ies) available for anordrin and Non-alcoholic-Fatty-Liver-Disease
| Article | Year |
|---|---|
Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity.
Tamoxifen is administered for estrogen receptor positive (ER Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Female; Heterografts; Humans; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Non-alcoholic Fatty Liver Disease; Norandrostanes; Tamoxifen; Treatment Outcome | 2017 |